상세 보기
자료 필터
자료유형
발행연도
2005 ~ 2038
2005 2038
키워드
언어
선택된 필터
- article
- conference
- book
전체 121건 중 1번부터 10번까지의 결과를 표시합니다.
2026
Article
Corrigendum to ‘Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies’: [ESMO Open Volume 11, Issue 7, July 2026, 107706] (S2059702926016480), (10.1016/j.esmoop.2026.107706)
- Kim, Ju Won ;
- Park, Y.H. ;
- Lee, SOOHYEON ;
- Ahn, H.K. ;
- Bae, J. ;
- ... Park, In Hae ;
- ... Choi, Jungyoon ;
- ... Park, Kyong Hwa ;
- 외 22명
- 2026-09
- ESMO Open
- BMJ PUBLISHING GROUP
Article
Treatment-free survival after two-year immune checkpoint inhibitor treatment in non-small cell lung cancer: Utilizing the Korean Health Insurance Review and Assessment Service database
- Lee, Kyoungmin ;
- Kang, Minwoong ;
- Namgung, Yoon ;
- Park, In Hae ;
- Choi, Yoon Ji ;
- ... Kim, Jung Sun ;
- ... Kang, Eun Joo
- 2026-08
- Lung Cancer
- Elsevier BV
Article
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies
- Kim, Ju Won ;
- Park, Y.H. ;
- Lee, SOOHYEON ;
- Ahn, H.K. ;
- Bae, J. ;
- ... Park, In Hae ;
- ... Choi, Jungyoon ;
- ... Park, Kyong Hwa ;
- 외 22명
- 2026-07
- ESMO Open
- BMJ PUBLISHING GROUP
Article
Clinical effect of bisphosphonate in patients with hormone receptor-positive early breast cancer: A nationwide real-world data analysis
- Choi, Wonseok ;
- Kang, Minwoong ;
- Lee, Kyoungmin ;
- Park, In Hae
- 2026-06
- Breast
- Churchill Livingstone
Article
Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?
- Park, Chanhee ;
- Park, In Hae ;
- Kim, Minhyuk ;
- Jang, Youngjoon ;
- Lim, Heuiseok ;
- 외 1명
- 2026-04
- JCO Clinical Cancer Informatics
- American Society of Clinical Oncology
2025
Article
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
- Im, S. A. ;
- Park, K. ;
- Koh, J. ;
- Park, C. ;
- Jung, K. H. ;
- ... Park, Kyong Hwa ;
- ... Park, In Hae ;
- 외 29명
- 2025-10
- ESMO Open
- BMJ PUBLISHING GROUP
Article
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)
- Lee, Jieun ;
- Lee, Dae-Won ;
- Kim, Min Hwan ;
- Kim, Jee Hung ;
- Kim, Ju Won ;
- ... Park, In Hae ;
- 외 19명
- 2025-08
- Breast
- Churchill Livingstone
Article
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
- Lee, Jieun ;
- Ahn, Hee-kyung ;
- Lee, Kyung-hun ;
- Jung, Kyung-hae ;
- Park, Yeonhee ;
- ... Park, KyongHwa ;
- ... Park, In Hae ;
- 외 23명
- 2025-08
- BMC Cancer
- BioMed Central
Article
Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10)
- Ahn, Hee Kyung ;
- Kim, Jee Hung ;
- Koh, Su-Jin ;
- Sohn, Joohyuk ;
- Kang, Myoung Joo ;
- ... Park, In Hae ;
- ... Park, Kyong Hwa ;
- 외 15명
- 2025-07
- The Lancet Regional Health. Western Pacific
- Elsevier
Conference
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after 2 or more HER2-directed chemotherapies (KM-10A/KCSG BR18-13).
- Kim, Ju Won ;
- Park, Yeon Hee ;
- Ahn, Hee Kyung ;
- Bae, Jihong ;
- Park, Suk-Young ;
- ... Park, In Hae ;
- ... Choi, Jung Yoon ;
- ... Park, KyongHwa ;
- 외 7명
- 2025-06-01
- 미국